122 related articles for article (PubMed ID: 17027885)
1. Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis.
Achiron A; Gurevich M
Autoimmun Rev; 2006 Oct; 5(8):517-22. PubMed ID: 17027885
[TBL] [Abstract][Full Text] [Related]
2. Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity.
Achiron A; Gurevich M; Friedman N; Kaminski N; Mandel M
Ann Neurol; 2004 Mar; 55(3):410-7. PubMed ID: 14991819
[TBL] [Abstract][Full Text] [Related]
3. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse.
Achiron A; Feldman A; Mandel M; Gurevich M
Ann N Y Acad Sci; 2007 Jun; 1107():155-67. PubMed ID: 17804543
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment.
Lindberg RL; Kappos L
Expert Rev Mol Diagn; 2006 Nov; 6(6):843-55. PubMed ID: 17140371
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.
Bomprezzi R; Ringnér M; Kim S; Bittner ML; Khan J; Chen Y; Elkahloun A; Yu A; Bielekova B; Meltzer PS; Martin R; McFarland HF; Trent JM
Hum Mol Genet; 2003 Sep; 12(17):2191-9. PubMed ID: 12915464
[TBL] [Abstract][Full Text] [Related]
6. Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis.
Achiron A; Gurevich M; Snir Y; Segal E; Mandel M
Clin Exp Immunol; 2007 Aug; 149(2):235-42. PubMed ID: 17488294
[TBL] [Abstract][Full Text] [Related]
7. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy.
Singh MK; Scott TF; LaFramboise WA; Hu FZ; Post JC; Ehrlich GD
J Neurol Sci; 2007 Jul; 258(1-2):52-9. PubMed ID: 17467740
[TBL] [Abstract][Full Text] [Related]
8. [Therapy monitoring in patients with multiple sclerosis based on transcriptomic analysis].
Zettl UK; Goertsches RH
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S64-8. PubMed ID: 19685398
[TBL] [Abstract][Full Text] [Related]
9. [Deficient mRNA expression of specific protein 3 gene in peripheral blood mononuclear cells from patients with multiple sclerosis].
Lin AY; Yang QD; Murong SX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):187-9. PubMed ID: 18393243
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications.
Niino M; Fukazawa T; Kikuchi S; Sasaki H
Expert Rev Neurother; 2007 Sep; 7(9):1175-88. PubMed ID: 17868016
[TBL] [Abstract][Full Text] [Related]
11. Gene-expression profiling of peripheral blood mononuclear cells in sepsis.
Tang BM; McLean AS; Dawes IW; Huang SJ; Lin RC
Crit Care Med; 2009 Mar; 37(3):882-8. PubMed ID: 19237892
[TBL] [Abstract][Full Text] [Related]
12. Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription.
Menon R; Di Dario M; Cordiglieri C; Musio S; La Mantia L; Milanese C; Di Stefano AL; Crabbio M; Franciotta D; Bergamaschi R; Pedotti R; Medico E; Farina C
J Autoimmun; 2012 May; 38(2-3):J144-55. PubMed ID: 22119415
[TBL] [Abstract][Full Text] [Related]
13. Genomics in multiple sclerosis--current state and future directions.
Comabella M; Martin R
J Neuroimmunol; 2007 Jul; 187(1-2):1-8. PubMed ID: 17400297
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling.
Lemmer ER; Friedman SL; Llovet JM
Semin Liver Dis; 2006 Nov; 26(4):373-84. PubMed ID: 17051451
[TBL] [Abstract][Full Text] [Related]
15. Current and future applications of transcriptomics for discovery in CNS disease and injury.
Munro KM; Perreau VM
Neurosignals; 2009; 17(4):311-27. PubMed ID: 19816067
[TBL] [Abstract][Full Text] [Related]
16. Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients.
Weinstock-Guttman B; Bhasi K; Badgett D; Tamaño-Blanco M; Minhas M; Feichter J; Patrick K; Munschauer F; Bakshi R; Ramanathan M
J Neuroimmunol; 2008 Dec; 205(1-2):113-25. PubMed ID: 18950872
[TBL] [Abstract][Full Text] [Related]
17. Novel interferon-beta-induced gene expression in peripheral blood cells.
Rani MR; Shrock J; Appachi S; Rudick RA; Williams BR; Ransohoff RM
J Leukoc Biol; 2007 Nov; 82(5):1353-60. PubMed ID: 17709400
[TBL] [Abstract][Full Text] [Related]
18. Translation towards personalized medicine in Multiple Sclerosis.
Miller A; Avidan N; Tzunz-Henig N; Glass-Marmor L; Lejbkowicz I; Pinter RY; Paperna T
J Neurol Sci; 2008 Nov; 274(1-2):68-75. PubMed ID: 18789804
[TBL] [Abstract][Full Text] [Related]
19. [Molecular biomarkers for prediction of multiple sclerosis relapse].
Satoh J
Nihon Rinsho; 2008 Jun; 66(6):1103-11. PubMed ID: 18540355
[TBL] [Abstract][Full Text] [Related]
20. Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation.
Takahashi N; Sato N; Takahashi S; Tojo A
Exp Hematol; 2008 Dec; 36(12):1760-1770. PubMed ID: 18814951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
